Corcept Therapeutics | CORT - Ebitda



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 11.65B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


Ebitda 更改 日
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
ANI Pharmaceuticals USD 71.6M 6.69M 2026-06
Ardelyx USD -29.77M 35.79M 2026-03
Aurora Cannabis CAD 3.7M 14.78M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Canopy Growth CAD -137M 134.13M 2026-03
Corcept Therapeutics USD -49M 53.2M 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
J&J USD 8.27B 1.08B 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Merck USD -1.54B 7.84B 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novartis USD 5.41B 431M 2026-03
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 48.67M 8.43M 2026-06
Pfizer USD 6.01B 18M 2026-06
Supernus Pharmaceuticals USD 31.6M 2.37M 2026-06
TG Therapeutics USD 26.9M 1.21M 2026-06